ACCENTIA BIOPHARMACEUTICALS INC Operating Cash Flow
ACCENTIA BIOPHARMACEUTICALS INC reported Operating Cash Flow of -$6.31 million for the 12-month period ending 2012-09-30, per its 10-K filed 2012-12-26.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2012-12-26
- ACCENTIA BIOPHARMACEUTICALS INC net cash provided by (used in) operating activities for the quarter ending 2012-09-30 was -$1.56M.
- ACCENTIA BIOPHARMACEUTICALS INC net cash provided by (used in) operating activities for the quarter ending 2012-06-30 was -$1.96M.
- ACCENTIA BIOPHARMACEUTICALS INC net cash provided by (used in) operating activities for the quarter ending 2012-03-31 was -$1.44M.
- ACCENTIA BIOPHARMACEUTICALS INC net cash provided by (used in) operating activities for the quarter ending 2011-12-31 was -$1.35M.
- ACCENTIA BIOPHARMACEUTICALS INC net cash provided by (used in) operating activities for fiscal 2012 was -$6.31M.
- ACCENTIA BIOPHARMACEUTICALS INC net cash provided by (used in) operating activities for fiscal 2011 was -$6.12M.
- ACCENTIA BIOPHARMACEUTICALS INC net cash provided by (used in) operating activities for fiscal 2010 was -$420.23K.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2012-09-30 | -$1.56M derived: 10-K 12 month − 10-Q 9 month · filed 2012-12-26 | -$3.52M derived: sum of 2 quarters · filed 2012-12-26 | -$4.96M derived: sum of 3 quarters · filed 2012-12-26 | -$6.31M 10-K · filed 2012-12-26 |
| 2012-06-30 | -$1.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-08-14 | -$3.40M derived: sum of 2 quarters · filed 2012-08-14 | -$4.75M 10-Q · filed 2012-08-14 | -$6.41M derived: sum of 4 quarters · filed 2012-12-26 |
| 2012-03-31 | -$1.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-05-15 | -$2.79M 10-Q · filed 2012-05-15 | -$4.45M derived: sum of 3 quarters · filed 2012-12-26 | -$6.43M derived: sum of 4 quarters · filed 2012-12-26 |
| 2011-12-31 | -$1.35M 10-Q · filed 2012-02-10 | -$3.01M derived: sum of 2 quarters · filed 2012-12-26 | -$4.98M derived: sum of 3 quarters · filed 2012-12-26 | -$6.16M derived: sum of 4 quarters · filed 2012-12-26 |
| 2011-09-30 | -$1.66M derived: 10-K 12 month − 10-Q 9 month · filed 2012-12-26 | -$3.64M derived: sum of 2 quarters · filed 2012-12-26 | -$4.81M derived: sum of 3 quarters · filed 2012-12-26 | -$6.12M 10-K · filed 2012-12-26 |
| 2011-06-30 | -$1.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-08-14 | -$3.15M derived: sum of 2 quarters · filed 2012-08-14 | -$4.46M 10-Q · filed 2012-08-14 | -$5.26M derived: sum of 4 quarters · filed 2012-08-14 |
| 2011-03-31 | -$1.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-05-15 | -$2.48M 10-Q · filed 2012-05-15 | -$3.29M derived: sum of 3 quarters · filed 2012-05-15 | |
| 2010-12-31 | -$1.30M 10-Q · filed 2012-02-10 | -$2.11M derived: sum of 2 quarters · filed 2012-02-10 | ||
| 2010-09-30 | -$807.60K derived: 10-K 12 month − 10-Q 9 month · filed 2011-12-19 | -$420.23K 10-K · filed 2011-12-19 | ||
| 2010-06-30 | $387.37K 10-Q · filed 2011-08-12 |